Skip to main content
Clinical Trials/NCT00568191
NCT00568191UnknownNot Applicable

Reliability of Threshold Algorithm in Age-Related Macular Degeneration: Stratus Versus Cirrus OCT

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery1 site in 1 country100 target enrollmentStarted: October 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Number of algorithm failures assessed by Stratus OCT versus Cirrus OCT in the horizontal central line

Study Overview

Brief Summary

The Cirrus OCT provides due to the spectral domain technology a 2-fold resolution than Stratus OCT generated in a comparable amount of time. Due to this higher resolution the retinal surface and the retinal pigment epithelium can be identified more clearly, a significantly reduced number of algorithm failures is expected

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
55 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age>55 years
  • Age-related macular degeneration

Exclusion Criteria

  • Not consented patients

Outcomes

Primary Outcomes

Number of algorithm failures assessed by Stratus OCT versus Cirrus OCT in the horizontal central line

Time Frame: only 1 examination

Secondary Outcomes

  • Number of algorrithm failures in Stratus versus Cirrus OCT assessed in the whole scan(1 examination)

Investigators

Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials